switching from tirzepatide to semaglutide for maintenance Tirzepatide: A Provider's Guide Switching from tirzepatide to semaglutide:
Description
A single class of drugs is changing how people think about weight, health and medicine.
New trial data for Amgen's GLP-1 drug MariTide shows a weight loss of 20 percent in non-diabetic participants with obesity or overweight.
Participants From a base population of 606434 US veterans with type 2 diabetes, participants were assigned to one of the two protocols and followed for up to three years
GLP-1 medications give most people sticker shock
mL = milliliter
Learn about Semaglutide and Tirzepatide to determine which is more effective for weight management
